965,649 shares sold at an average of $2.32 to fund corporate purposes
By Devika Patel
Knoxville, Tenn., Aug. 17 – Nymox Pharmaceutical Corp. said it completed a $2.24 million private placement of stock.
The company sold 965,649 common shares at an average price of $2.32 apiece. The price-per-share is a 15.42% premium to the June 15 closing share price of $2.01.
Proceeds will be used for general corporate purposes.
Hasbrouck, N.J.-based Nymox is a biotechnology company focused on needs of the aging population.
| Issuer: | Nymox Pharmaceutical Corp.
|
| Issue: | Common stock
|
| Amount: | $2.24 million
|
| Shares: | 965,649
|
| Price: | $2.32 (average)
|
| Warrants: | No
|
| Settlement date: | Aug. 17
|
| Stock symbol: | Nasdaq: NYMX
|
| Stock price: | $2.01 at close Aug. 16
|
| Market capitalization: | $90.02 million
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
